Feb 28 (Reuters) - U.S. health regulators on Tuesday issued an import alert for drug ingredients and products related to Xylazine, used largely as a veterinary tranquilizer but has been a drug of ...

Xylazine, commonly manufactured in China, is a pharmaceutical ... makes FDA-approved xylazine, state-licensed compounding pharmacies or licensed veterinarians. Under the import alert, xylazine ...

Feb. 28, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration announced that it has taken action to restrict the unlawful entry of xylazine active pharmaceutical ingredients and ...

Last month, Sun Pharma exuded confidence in meeting its growth guidance despite the United States Food and Drug Administration (USFDA) placing the company's Halol facility under an import alert. The ...

The company intends to increase its specialty drug portfolio in its core areas ... The company’s Halol plant, receiving an import alert from the USFDA earlier in December, remains a challenge for Sun.

we also realize that PhAROS has the potential to be of high value to other drug development biotech and pharmaceutical companies. With its data analytics and machine learning capabilities ...

The FDA has placed xylazine on an import alert for detention without physical examination of the active pharmaceutical ingredient and unapproved finished drug products. Xylazine is approved for use in ...

Feb. 28, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration announced that it has taken action to restrict the unlawful entry of xylazine active pharmaceutical ingredients ... into the ...

The Food and Drug Administration is continuing its use of import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as needed.